New Cancer Drug Delivery Method

The Scripps Research Institute (TSRI) from the Florida campus have developed a new drug delivery method that produces strong results in treating cancers in animal models that includes some hard-to-treat solid and liquid tumors. TSRI Associate Professor Christoph Rader led the study, and the article was published online in the journal Cell Chemical Biology.

A class of pharmaceuticals known as antibody-drug conjugates (ADCs) includes some of the most promising next-generation antibody therapeutics for cancer. A cytotoxic payload can be delivered in a way that is tumor-selective and 3 of the ADCs have been approved by the U.S. Food and Drug Administration …read more